Presentation Information
[P069]Targeting the collagen-immune axis in glioblastoma: disrupting DDR1-mediated immune evasion using preclinical GEMMs and pharmacologic inhibitors
○Syed M. Faisal1,2,3, Andrea Comba1,2,3, Maria L Varela1,2,3, Maria G Castro1,2,3, Pedro R Lowenstein1,2,3 (1. Department of Neurosurgery, University of Michigan Medical School, Ann Arbor, MI, USA (United States of America), 2. Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, USA (United States of America), 3. Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA (United States of America))
Password required to view
Comment
To browse or post comments, you must log in.Log in